A citation-based method for searching scientific literature

Liang Xu, Ye Chen, Yulun Huang, Edwin Sandanaraj, John S Yu, Ruby Yu-Tong Lin, Pushkar Dakle, Xin-Yu Ke, Yuk Kien Chong, Lynnette Koh, Anand Mayakonda, Kassoum Nacro, Jeffrey Hill, Mo-Li Huang, Sigal Gery, See Wee Lim, Zhengyun Huang, Ying Xu, Jianxiang Chen, Longchuan Bai, Shaomeng Wang, Hiroaki Wakimoto, Tseng Tsai Yeo, Beng Ti Ang, Markus Müschen, Carol Tang, Tuan Zea Tan, H Phillip Koeffler. Sci Adv 2021
Times Cited: 6







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


eIF4E phosphorylation regulates ongoing pain, independently of inflammation, and hyperalgesic priming in the mouse CFA model.
Jamie K Moy, Jasper L Kuhn, Thomas A Szabo-Pardi, Grishma Pradhan, Theodore J Price. Neurobiol Pain 2018
21
33

Distinct conformational states of SARS-CoV-2 spike protein.
Yongfei Cai, Jun Zhang, Tianshu Xiao, Hanqin Peng, Sarah M Sterling, Richard M Walsh, Shaun Rawson, Sophia Rits-Volloch, Bing Chen. Science 2020
508
33

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
Daniel Wrapp, Nianshuang Wang, Kizzmekia S Corbett, Jory A Goldsmith, Ching-Lin Hsieh, Olubukola Abiona, Barney S Graham, Jason S McLellan. Science 2020
33

SARS-CoV-2 variants, spike mutations and immune escape.
William T Harvey, Alessandro M Carabelli, Ben Jackson, Ravindra K Gupta, Emma C Thomson, Ewan M Harrison, Catherine Ludden, Richard Reeve, Andrew Rambaut, Sharon J Peacock,[...]. Nat Rev Microbiol 2021
910
33

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Alexandra C Walls, Young-Jun Park, M Alejandra Tortorici, Abigail Wall, Andrew T McGuire, David Veesler. Cell 2020
33

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
Yongfei Cai, Jun Zhang, Tianshu Xiao, Christy L Lavine, Shaun Rawson, Hanqin Peng, Haisun Zhu, Krishna Anand, Pei Tong, Avneesh Gautam,[...]. Science 2021
96
33

Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.
Tzu-Jing Yang, Pei-Yu Yu, Yuan-Chih Chang, Kang-Hao Liang, Hsian-Cheng Tso, Meng-Ru Ho, Wan-Yu Chen, Hsiu-Ting Lin, Han-Chung Wu, Shang-Te Danny Hsu. Nat Struct Mol Biol 2021
54
33

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.
Donald J Benton, Antoni G Wrobel, Pengqi Xu, Chloë Roustan, Stephen R Martin, Peter B Rosenthal, John J Skehel, Steven J Gamblin. Nature 2020
310
33

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.
Sophie M-C Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Victoria Stalls, Megan F Kopp, Kartik Manne, Dapeng Li, Kevin Wiehe,[...]. Science 2021
144
33

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
33


Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.
D S Markovic, K Vinnakota, S Chirasani, M Synowitz, H Raguet, K Stock, M Sliwa, S Lehmann, R Kälin, N van Rooijen,[...]. Proc Natl Acad Sci U S A 2009
266
16

Environmental stimuli shape microglial plasticity in glioma.
Stefano Garofalo, Alessandra Porzia, Fabrizio Mainiero, Silvia Di Angelantonio, Barbara Cortese, Bernadette Basilico, Francesca Pagani, Giorgio Cignitti, Giuseppina Chece, Roberta Maggio,[...]. Elife 2017
32
16


Review: molecular mechanism of microglia stimulated glioblastoma invasion.
Salvatore J Coniglio, Jeffrey E Segall. Matrix Biol 2013
72
16

CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity.
Miriam Sciaccaluga, Bernard Fioretti, Luigi Catacuzzeno, Francesca Pagani, Cristina Bertollini, Maria Rosito, Myriam Catalano, Giuseppina D'Alessandro, Antonio Santoro, Giampaolo Cantore,[...]. Am J Physiol Cell Physiol 2010
84
16

Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment.
Pulak Ranjan Nath, Dipasmita Pal-Nath, Ajeet Mandal, Margaret C Cam, Anthony L Schwartz, David D Roberts. Cancer Immunol Res 2019
33
16

Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma.
Gang Zhao, Jun Jia, Lansheng Wang, Yongkang Zhang, Han Yang, Yang Lu, Rutong Yu, Hongmei Liu, Yufu Zhu. Onco Targets Ther 2020
5
20

The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Costas D Arvanitis, Gino B Ferraro, Rakesh K Jain. Nat Rev Cancer 2020
406
16

HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice.
Cristina Picci, Victor S C Wong, Christopher J Costa, Marion C McKinnon, David C Goldberg, Michelle Swift, Nazia M Alam, Glen T Prusky, Sida Shen, Alan P Kozikowski,[...]. Exp Neurol 2020
21
16

Current concepts and management of glioblastoma.
Matthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, Sara C Erridge, Monika Hegi, Michael Weller, Roger Stupp. Ann Neurol 2011
306
16

HDAC8: a multifaceted target for therapeutic interventions.
Alokta Chakrabarti, Ina Oehme, Olaf Witt, Guilherme Oliveira, Wolfgang Sippl, Christophe Romier, Raymond J Pierce, Manfred Jung. Trends Pharmacol Sci 2015
134
16

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.
Michael C Burger, Congcong Zhang, Patrick N Harter, Annette Romanski, Florian Strassheimer, Christian Senft, Torsten Tonn, Joachim P Steinbach, Winfried S Wels. Front Immunol 2019
82
16

Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
Konrad Gabrusiewicz, Benjamin Rodriguez, Jun Wei, Yuuri Hashimoto, Luke M Healy, Sourindra N Maiti, Ginu Thomas, Shouhao Zhou, Qianghu Wang, Ahmed Elakkad,[...]. JCI Insight 2016
237
16

EZH2 function in immune cell development.
Stephen L Nutt, Christine Keenan, Michaël Chopin, Rhys S Allan. Biol Chem 2020
24
16

Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis.
Stefano Garofalo, Germana Cocozza, Alessandra Porzia, Maurizio Inghilleri, Marcello Raspa, Ferdinando Scavizzi, Eleonora Aronica, Giovanni Bernardini, Ling Peng, Richard M Ransohoff,[...]. Nat Commun 2020
40
16

Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment.
Helle Jensen, Michael Hagemann-Jensen, Felicia Lauridsen, Søren Skov. Mol Immunol 2013
8
16

Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice.
Stefano Garofalo, Giuseppina D'Alessandro, Giuseppina Chece, Frederic Brau, Laura Maggi, Alessandro Rosa, Alessandra Porzia, Fabrizio Mainiero, Vincenzo Esposito, Clotilde Lauro,[...]. Nat Commun 2015
81
16

Epigenomic Reprogramming as a Driver of Malignant Glioma.
Richard E Phillips, Alexey A Soshnev, C David Allis. Cancer Cell 2020
24
16

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells.
Olga Pastorino, Maria Teresa Gentile, Alessandro Mancini, Nunzio Del Gaudio, Antonella Di Costanzo, Adriana Bajetto, Paola Franco, Lucia Altucci, Tullio Florio, Maria Patrizia Stoppelli,[...]. Cancers (Basel) 2019
19
16

Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.
Teresa Bellissimo, Federica Ganci, Enzo Gallo, Andrea Sacconi, Claudia Tito, Luciana De Angelis, Claudio Pulito, Silvia Masciarelli, Daniele Diso, Marco Anile,[...]. Mol Cancer 2017
18
16

Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.
Konrad Gabrusiewicz, Aleksandra Ellert-Miklaszewska, Maciej Lipko, Malgorzata Sielska, Marta Frankowska, Bozena Kaminska. PLoS One 2011
193
16

HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1.
Irene Santos-Barriopedro, Yixuan Li, Sonali Bahl, Edward Seto. Genes Cancer 2019
13
16

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
16

Targeting of HDAC8 and investigational inhibitors in neuroblastoma.
Ina Oehme, Hedwig E Deubzer, Marco Lodrini, Till Milde, Olaf Witt. Expert Opin Investig Drugs 2009
58
16

Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function.
January M Watters, Gabriela Wright, Matthew A Smith, Bijal Shah, Kenneth L Wright. Biochem Biophys Res Commun 2021
3
33

The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review.
Hope S Rugo, Ira Jacobs, Shikhar Sharma, Frank Scappaticci, Thomas A Paul, Kristen Jensen-Pergakes, Gabriel G Malouf. Adv Ther 2020
34
16

Microglia as Dynamic Cellular Mediators of Brain Function.
Elizabeth C Wright-Jin, David H Gutmann. Trends Mol Med 2019
36
16

Chromatin proteins and modifications as drug targets.
Kristian Helin, Dashyant Dhanak. Nature 2013
309
16



Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
G R Vanaja, Hemalatha Golaconda Ramulu, Arunasree M Kalle. Cell Commun Signal 2018
30
16

Targeting EZH2 in cancer.
Kimberly H Kim, Charles W M Roberts. Nat Med 2016
784
16

Histone-deacetylase 8 drives the immune response and the growth of glioma.
Alessandro Mormino, Germana Cocozza, Giulia Fontemaggi, Sergio Valente, Vincenzo Esposito, Antonio Santoro, Giovanni Bernardini, Angela Santoni, Francesco Fazi, Antonello Mai,[...]. Glia 2021
4
25

EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
Yatao Yin, Shuwei Qiu, Xiangpen Li, Bo Huang, Yun Xu, Ying Peng. J Neuroinflammation 2017
47
16

The polycomb group protein EZH2 is involved in progression of prostate cancer.
Sooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, Terrence R Barrette, Chandan Kumar-Sinha, Martin G Sanda, Debashis Ghosh, Kenneth J Pienta, Richard G A B Sewalt, Arie P Otte,[...]. Nature 2002
16

Epigenetics in Brain Tumors: HDACs Take Center Stage.
Ilker Y Eyüpoglu, Nicolai E Savaskan. Curr Neuropharmacol 2016
16
16

NK Cell-Based Glioblastoma Immunotherapy.
Irene Golán, Laura Rodríguez de la Fuente, Jose A Costoya. Cancers (Basel) 2018
34
16

Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
Jakub Mieczkowski, Marta Kocyk, Pawel Nauman, Konrad Gabrusiewicz, Małgorzata Sielska, Piotr Przanowski, Marta Maleszewska, Wenson D Rajan, Dominika Pszczolkowska, Tomasz Tykocki,[...]. Oncotarget 2015
42
16

Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.
Philip Lee, Ben Murphy, Rickey Miller, Vivek Menon, Naren L Banik, Pierre Giglio, Scott M Lindhorst, Abhay K Varma, William A Vandergrift, Sunil J Patel,[...]. Anticancer Res 2015
52
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.